MEDP

Q: What is the price of Medpace Holdings (MEDP) today?

The price of Medpace Holdings (MEDP) today is R$ 2.543,55, with a variation of 21.8% compared to the last year. The price of Medpace Holdings (MEDP) started the year trading around R$ 1.800,69 and today it is at R$ 2.543,55. Follow the real-time price chart, the historical price of Medpace Holdings (MEDP), and stock data from Ibovespa and international markets.

Q: When does Medpace Holdings (MEDP) pay dividends?

Medpace Holdings (MEDP) did not distribute dividends in the last year.

Q: Medpace Holdings (MEDP) is it worth it?

Currently, Medpace Holdings (MEDP) is priced at R$ 2.543,55, with a P/E of 32,14%, representing a deviation of 33,10% from its historical average P/E. In the last year, the stock showed a variation of 21.8% in its price and distributed R$ 0,00 in dividends, resulting in a Dividend Yield of 0,00%. The total shareholder return was 21,80%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How to buy shares of Medpace Holdings (MEDP)?

Investing in shares of Medpace Holdings (MEDP) can be done in two ways: by buying the stock abroad or the BDR in Brazil (if available). The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.The BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much do 100 shares of Medpace Holdings (MEDP) yield today?

The yield of Medpace Holdings (MEDP) was 4,87% in the last month, 21,80% in the last year and 0,00% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of R$ 0,00 in dividends, um Dividend Yield de 0,00%.If you wanted to buy 100 shares of Medpace Holdings (MEDP) today, the total investment would be based on the current price of R$ 2.543,55.If past performance were to repeat, the return on your investment would be:In 1 year: R$ 309.804,61In 5 years: R$ 254.355,18In 10 years: 254.355,18It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Medpace Holdings Inc.

Price

US$ 469,29

variation (12m)

21,80%

p/l

32,14

p/vp

78,01

DIVIDEND YIELD

0,00%

quote MEDP

BVMF

MEDP

If you had invested

year ago

6 months

1 year

5 years

10 years

today you would have

today you would have:

*The figure considers the reinvestment of dividends.

profitability of MEDP

1 month

3 months

1 year

2 years

5 years

10 years

profitability

1 month

4,87%

3 months

59,73%

1 year

21,80%

2 years

80,62%

5 years

0,00%

10 years

0,00%

real profitability

profitability minus inflation.

1 month

4,87%

3 months

58,93%

1 year

15,73%

2 years

64,64%

5 years

0,00%

10 years

0,00%

Indicators MEDP

check out the fundamentals of Medpace Holdings shares

P/L

32,14

Sector: -3,27 Industry: -3,27

P/SALES (PSR)

6,02

Sector: -3,77 Industry: -3,77

P/VP

78,01

Sector: 1,74 Industry: 1,74

DIVIDEND YIELD (DY)

0,00%

Sector: - Industry: -

ROA

26,62%

Sector: -63,50% Industry: -63,50%

ROE

242,70%

Sector: -67,23% Industry: -67,23%

ROIC

18,90%

Sector: -2.087,74% Industry: -2.087,74%

Net Margin

18,74%

Sector: -43,34% Industry: -43,34%

GROSS MARGIN

31,62%

Sector: 40,50% Industry: 40,50%

OPERATING MARGIN

21,40%

Sector: -43,21% Industry: -43,21%

P/EBITDA

26,55

Sector: -3,13 Industry: -3,13

P/EBIT

28,16

Sector: -3,41 Industry: -3,41

P/ASSETS

8,55

Sector: 1,29 Industry: 1,29

VPA

5,94

Sector: 1,80 Industry: 1,80

LPA

14,42

Sector: -2,09 Industry: -2,09

EQUITY / ASSETS

0,11

Sector: 0,42 Industry: 0,42

CAGR REVENUES 5 YEARS

19,24%

Sector: - Industry: -

CAGR PROFITS 5 YEARS

23,56%

Sector: - Industry: -

FAIR PRICE OF Medpace Holdings ASSETS ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Price

The Fair Price formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffet's mentor.

Current price

US$ 469,29

Fair Price

US$ 0,00

Upside Potencial de rentabilidade.

-90,65%

See Graham's ranking

Because it considers equity value in its calculation, the formula does not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

MEDP indicators history

DRAG THE FRAME TO SEE MORE DATA

comparator of Stocks

DRAG THE FRAME TO SEE MORE DATA

	p/l	p/vp	ROE	dy	market value	Net Margin
JNJ	19,04	5,50	28,88%	2,80%	US$ 431,37 B	25,00%
PFE	13,45	1,62	12,08%	6,68%	US$ 144,63 B	16,84%
ABBV	79,66	228,58	286,94%	3,38%	US$ 334,19 B	7,31%
NVO	15,51	9,75	62,86%	2,83%	US$ 253,39 B	35,63%
MRK	13,05	4,36	33,44%	3,75%	US$ 214,13 B	25,79%
BMY	19,31	5,58	28,87%	5,13%	US$ 97,52 B	10,58%
GILD	22,64	7,29	32,21%	2,72%	US$ 142,89 B	21,87%
AZN	30,26	5,60	18,51%	1,91%	US$ 251,01 B	14,68%
ZTS	26,68	14,00	52,48%	1,19%	US$ 69,70 B	27,83%
HALO	15,59	26,12	167,47%	0,00%	US$ 8,69 B	47,28%
REGN	13,88	2,07	14,89%	0,30%	US$ 61,90 B	31,37%
AMGN	23,87	21,27	89,11%	3,15%	US$ 158,02 B	18,96%
VRTX	27,92	5,91	21,18%	0,00%	US$ 101,55 B	31,86%
ADMA	20,53	10,77	52,45%	0,00%	US$ 4,29 B	44,06%
MCK	27,24	-99,86	-366,63%	0,41%	US$ 86,18 B	0,84%
BIIB	13,38	1,16	8,68%	0,00%	US$ 20,48 B	15,31%
CAH	22,58	-13,38	-59,26%	1,37%	US$ 35,25 B	0,70%

comparison of MEDP with indexes

If you had invested (change) 2 years a year ago, today you would have

R$ 1.000,00 in PETR4 you would have R$ 2.294,60

R$ 1.000,00 in LEVE3 you would have R$ 5.240,60

*The value considers the reinvestment of dividends.

dividend history MEDP dividend history

Current DY: 0,00%

5-year average DY: 0,00%

no dividend paid in the period.

ABOUT THE COMPANY Medpace Holdings

Medpace Holdings Inc.

Average user rating I10

4.0 (3 people)

Estados Unidos

11 years

Foundation: 2014

2016

Year of debut on the stock exchange - 9 years

3.500

Employees

The Company Medpace Holdings Inc. (Estados Unidos), is listed on Nasdaq with a market value of $ 13,45 Billions, having a net worth of $ 172,35 Milhões.

With a total of 3.500 employees, the company is listed in the sector of Cuidados de saúde and categorized in industry of Biotecnologia.

In the last 12 months the Company had a revenue of $ 2,23 Billions, which generated a profit in the amount of $ 418,30 Milhões.

As for its main indicators, the Company has a P/E ratio of 32,14, a P/B ratio of 78,01 and in the last 12 months the Company did not pay dividends.

The Company is traded through the ticker MEDP.

Market value

US$ 13,45 Billions

Net worth

US$ 172,35 Milhões

US$ 172.350.000,00

Assets

US$ 1,57 Billion

US$ 1.571.670.000,00

Total Number of Shares

29,00 Milhões

29.000.000

Average Daily Trading Volume

US$ 546,72 Thousand

US$ 546.723,82

Sector

Cuidados de saúde

Industry

Biotecnologia

MEDP

MEDP revenue and profits

MEDP results

DRAG THE FRAME TO SEE MORE DATA

MEDP cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

US$ - -0,00% (12M)

P/L

0,00

0,00%

ROE

-893,55%

P/VP

0,00

MCK - McKesson

US$ 680,52 24,27% (12M)

P/L

27,24

0,41%

ROE

-366,63%

P/VP

-99,86

CAH - Cardinal Health

US$ 147,49 36,56% (12M)

P/L

22,58

1,37%

ROE

-59,26%

P/VP

-13,38

JNJ - Johnson & Johnson

US$ 176,49 12,66% (12M)

P/L

19,04

2,80%

ROE

28,88%

P/VP

5,50

MRK - Merck & Co.

US$ 84,99 --23,85% (12M)

P/L

13,05

3,75%

ROE

33,44%

P/VP

4,36

PFE - Pfizer

US$ 24,92 --5,92% (12M)

P/L

13,45

6,68%

ROE

12,08%

P/VP

1,62

AZN - AstraZeneca

US$ 80,05 --5,68% (12M)

P/L

30,26

1,91%

ROE

18,51%

P/VP

5,60

ABBV - AbbVie

US$ 208,36 10,15% (12M)

P/L

79,66

3,38%

ROE

286,94%

P/VP

228,58

BFRA - Biofrontera

US$ - -0,00% (12 M)

P/L

0,00

0,00%

ROE

-893,55%

P/VP

0,00

MCK - McKesson

US$ 680,52 24,27% (12 M)

P/L

27,24

0,41%

ROE

-366,63%

P/VP

-99,86

CAH - Cardinal Health

US$ 147,49 36,56% (12 M)

P/L

22,58

1,37%

ROE

-59,26%

P/VP

-13,38

JNJ - Johnson & Johnson

US$ 176,49 12,66% (12 M)

P/L

19,04

2,80%

ROE

28,88%

P/VP

5,50

MRK - Merck & Co.

US$ 84,99 --23,85% (12 M)

P/L

13,05

3,75%

ROE

33,44%

P/VP

4,36

PFE - Pfizer

US$ 24,92 --5,92% (12 M)

P/L

13,45

6,68%

ROE

12,08%

P/VP

1,62

AZN - AstraZeneca

US$ 80,05 --5,68% (12 M)

P/L

30,26

1,91%

ROE

18,51%

P/VP

5,60

ABBV - AbbVie

US$ 208,36 10,15% (12 M)

P/L

79,66

3,38%

ROE

286,94%

P/VP

228,58

Common Questions

What is the price of Medpace Holdings (MEDP) today?

The price of Medpace Holdings (MEDP) today is R$ 2.543,55, with a variation of 21.8% compared to the last year. The price of Medpace Holdings (MEDP) started the year trading around R$ 1.800,69 and today it is at R$ 2.543,55. Follow the real-time price chart, the historical price of Medpace Holdings (MEDP), and stock data from Ibovespa and international markets.

When does Medpace Holdings (MEDP) pay dividends?

Medpace Holdings (MEDP) did not distribute dividends in the last year.

Medpace Holdings (MEDP) is it worth it?

Currently, Medpace Holdings (MEDP) is priced at R$ 2.543,55, with a P/E of 32,14%, representing a deviation of 33,10% from its historical average P/E. In the last year, the stock showed a variation of 21.8% in its price and distributed R$ 0,00 in dividends, resulting in a Dividend Yield of 0,00%. The total shareholder return was 21,80%.

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

How to buy shares of Medpace Holdings (MEDP)?

Investing in shares of Medpace Holdings (MEDP) can be done in two ways: by buying the stock abroad or the BDR in Brazil (if available). The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.

The BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

How much do 100 shares of Medpace Holdings (MEDP) yield today?

The yield of Medpace Holdings (MEDP) was 4,87% in the last month, 21,80% in the last year and 0,00% in the last 5 years (already considering appreciation and dividends).

In the last 12 months, the company paid a total of R$ 0,00 in dividends, um Dividend Yield de 0,00%.

If you wanted to buy 100 shares of Medpace Holdings (MEDP) today, the total investment would be based on the current price of R$ 2.543,55.

If past performance were to repeat, the return on your investment would be:

In 1 year: R$ 309.804,61
In 5 years: R$ 254.355,18
In 10 years: 254.355,18

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

MEDP

Medpace Holdings Inc.

Price

variation (12m)

p/l

p/vp

DIVIDEND YIELD

profitability of MEDP

check out the fundamentals of Medpace Holdings shares

P/L

P/SALES (PSR)

P/VP

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

Net Margin

GROSS MARGIN

OPERATING MARGIN

P/EBITDA

P/EBIT

P/ASSETS

VPA

LPA

EQUITY / ASSETS

CAGR REVENUES 5 YEARS

CAGR PROFITS 5 YEARS

Graham's Fair Price

If you had invested (change) 2 years a year ago, today you would have

Current DY: 0,00%

5-year average DY: 0,00%

ABOUT THE COMPANY Medpace Holdings

Medpace Holdings Inc.

Estados Unidos

11 years

2016

3.500

PROFIT X PRICE MEDP

MEDP results

MEDP cash flow

evolution of assets - MEDP

MEDP balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

PFE - Pfizer

AZN - AstraZeneca

ABBV - AbbVie

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

PFE - Pfizer

AZN - AstraZeneca

ABBV - AbbVie

Common Questions

Tudo que o investidor precisa em um só lugar

Pague 2, Leve 3

Anual

Valor total R$ 238,80